☰ Navigation Tabs
Uncrossed Fab binding to human Angiopoietin 2 External Resource: Annotation Chains Family Name Domain Identifier Architecture Possible Homology Homology Topology Family Provenance Source (Version) D Ig_2 e4imkD3 A: alpha arrays X: Subtilisin-like H: Subtilisin-like T: Subtilisin-like F: Ig_2 ECOD (v295.2) C Rhv e4imkC1 A: alpha arrays X: HTH H: HTH T: Catalytic domain of hepatitis C virus NS2-3 protease F: Rhv ECOD (v295.2) A 14-3-3 e4imkA1 A: alpha arrays X: beta-Grasp H: Ubiquitin-related T: Ubiquitin-like F: 14-3-3 ECOD (v295.2) B Rhv e4imkB1 A: alpha arrays X: HTH H: HTH T: Catalytic domain of hepatitis C virus NS2-3 protease F: Rhv ECOD (v295.2)
Chain Protein Name Description Organism Name Gene Allele Name(s) Domain Name(s) Receptor Type Receptor Description Provenance Source Fab, anti-Ang2 V-LAMBDA-C-KAPPA Homo sapiens (human) IGLV3-21*02, IGLJ1*01, IGKC*01 V-DOMAIN V-LAMBDA, C-DOMAIN C-KAPPA IG FAB-GAMMA-1_V-LAMBDA-C-KAPPA IMGT (202636-0) Fab, anti-Ang2 VH-CH1 Homo sapiens (human) IGHV1-2*02, IGHJ3*02, IGHG1*01, IGHG1*02, IGHG1*04 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_V-LAMBDA-C-KAPPA IMGT (202636-0)
Chain Chain Class Chain Subclass Chain Type Antigen Name(s) Provenance Source Light Chain IGLV3 Lambda - SAbDab (2026-09-18) Heavy Chain IGHV1 - - SAbDab (2026-09-18)
Chain Name Target Provenance Source Vanucizumab ANGPT2, VEGFA Therapeutic SAbDab (2026-09-18) Vanucizumab ANGPT2, VEGFA Therapeutic SAbDab (2026-09-18)